In: PATENT NEWS
Some New Papers on the Appropriate Royalty Base for FRAND-Committed Patents. 1. Fredrick Nilsson has published a paper titled Appropriate Base to Determine a Fair Return on Investment: A Legal and Economic Perspective on FRAND, in the December 2017 issue of GRUR Int. (pp. 1017-1023).
In: PATENT NEWS
2017:1 KEI Briefing Note: Bayh-Dole Act and difference between March-In Rights and the world wide royalty free rights in patents; Feb. 24, 2017 Compulsory Licensing Workshop – Panel Discussion, 28 U.S.C. 1498. There have been a large number of cases where 1498 has been used, and we’ll add …
In: PATENT NEWS
The Patent Act itself actually says that patents are property. The statute succinctly explains: “patents shall have the attributes of personal property.” 35 U.S.C. §261. Yet, to the Trump Justice Department, patents are simply a public right — a government franchise capable of being annulled without …
In: PATENT NEWS
Law360 (February 21, 2018, 12:14 PM EST) — Over the past 25 years, technology has advanced at a breakneck, disruptive pace. Since 1990, we have seen the introduction of digital cameras, smartphones, drones, the “internet-of-things,” gene editing through clustered regularly interspaced short …
In: PATENT NEWS
Search for Biotech Patent Attorney jobs at Monster. Executive Summary The biotechnology industry is vital to human progress and America’s economy. Biotech Patent Law with a new chapter and a new appendix on biologics and biosimilars, discussion of recent case law, and more. D. D DISCLAIMER: …
In: PATENT NEWS
International report – Patent licensing business model attracts attention IAM (blog) Full coverage
In: PATENT NEWS
International report – Are UK companies making best use of the patent system? IAM (blog) Full coverage
In: PATENT NEWS
UPDATE–CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized … GlobeNewswire (press release) Full coverage
In: PATENT NEWS
Stryde Technologies Granted Patent For Shielded Inductors PR Newswire (press release) Full coverage
In: PATENT NEWS
Cyclacel Pharma (CYCC) Announces New European Patent Covering Sapacitabine Pharmaceutical Formulations StreetInsider.com Cyclacel nabs sapacitabine patent in Europe; shares ahead 6% premarket Seeking Alpha Cyclacel Pharmaceuticals (CYCC) Stock: Gaining Big On Patent News CNA Finance Full coverage
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION